Arcellx (ACLX) EBITDA Margin (2023 - 2025)

Arcellx (ACLX) recorded quarterly EBITDA Margin of 3505.14% in Q4 2025, down 209.59% quarter-over-quarter from 1132.2% in Q3 2025, and down 318985.0% on a YoY basis from N/an in Q4 2024.

Arcellx (ACLX) EBITDA Margin (2023 - 2025) Analysis & Trends

Arcellx's EBITDA Margin history runs 3 years deep, the most recent figure standing at 3505.14% for Q4 2025.

  • In Q4 2025, EBITDA Margin fell 318985.0% year-over-year to 3505.14%; the TTM figure through Dec 2025 stood at 1027.42% (down 92824.0% YoY), while the FY2025 annual figure was 1027.28%, down 92810.0% from the prior year.
  • EBITDA Margin was 3505.14% for Q4 2025 at Arcellx, down from 1132.2% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 32.39% in Q4 2023 to a low of 3505.14% in Q4 2025.
  • Historically, EBITDA Margin has averaged 598.21% across 3 years, with a median of 215.41% in 2023.
  • The sharpest annual moves came in 2024 and 2025: EBITDA Margin surged 17435 bps in 2024, then sank 318985 bps in 2025.
  • A 3-year view of EBITDA Margin shows it stood at 32.39% in 2023, then slumped by 1073 bps to 315.29% in 2024, then sank by 1012 bps to 3505.14% in 2025.
  • The last three EBITDA Margin figures came in at 3505.14% (Q4 2025), 1132.2% (Q3 2025), and 697.59% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -6.43%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 38.10%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Arcellx 6.48 Bn 6.48 Bn - -3,505.14%

Historic Data

Download Data
DateValue
Dec 31, 2025 -3,505.14%
Sep 30, 2025 -1,132.20%
Jun 30, 2025 -697.59%
Mar 31, 2025 -768.47%
Dec 31, 2024 -315.29%
Sep 30, 2024 -89.04%
Jun 30, 2024 -100.36%
Mar 31, 2024 -21.03%
Dec 31, 2023 32.39%
Sep 30, 2023 -263.38%
Jun 30, 2023 -167.44%
Mar 31, 2023 -150.94%